Gwillym Preece

Gwillym Preece

Public Health and Microbiology

MPH Public Health, BSc Microbiology

Gwillym has a strong passion for understanding new developments in science, particularly those within microbiology and infectious disease control. He has a B.Sc. in microbiology from the University of Sheffield where he gained knowledge in the molecular mechanisms of infectious disease, with a particular focus on tuberculosis and Staphylococcus aureus.

Through this, he developed an interest in a public health approach to infectious disease control, which led him to pursue an M.P.H. in public health also at the University of Sheffield. This enabled him to develop skills in epidemiology and research methods applicable to his area of interest.

His master’s dissertation was a systematic review and meta-analysis focused on determining any association between sputum smear result and the prevalence of multiple drug-resistant tuberculosis (MDR-TB) in tuberculosis patients. This developed skills in taking a detail-oriented approach to analyzing a high volume of data, which he applies to all areas of his work.

In undertaking this work he also gained a deeper understanding of the impact of social factors such as homelessness, drug use and alcoholism on the prevalence of MDR-TB. So, also understanding the wider social and political context around the disease.

In addition to tuberculosis, Gwillym has particular interests in antimicrobial resistance (AMR) and neglected tropical diseases (NTDs), such as onchocerciasis and schistosomiasis. AMR will be one of the key medical problems of the coming decades, and we must be able to have effective antimicrobials or find new ways to fight infectious diseases.

The interest in the NTDs is based on a desire to improve the quality of life for the most vulnerable and isolated people who are most affected by these diseases. The basis of NTDs is often in low socio-economic development, for example, schistosomiasis would largely be prevented by proper sanitation.

Gwillym enjoys using writing opportunities to expand his knowledge of scientific concepts, allowing him to apply this knowledge to future areas of work. Writing for AZoNetwork allows him to learn about new developments in molecular biology and public health that contribute to the improvement of medicine and human health.

Articles from Gwillym

Recent Advancements in Monoclonal Antibodies

Recent Advancements in Monoclonal Antibodies

Could CRISPR be used to Create New Species?

Could CRISPR be used to Create New Species?

What is non-coding RNA (ncRNA)?

What is non-coding RNA (ncRNA)?

Role of ncRNA in Drug Discovery

Role of ncRNA in Drug Discovery

What are Neutrophils?

What are Neutrophils?

What are Aptamers?

What are Aptamers?

What is Competing Endogenous RNA?

What is Competing Endogenous RNA?

What is Immune Checkpoint Therapy?

What is Immune Checkpoint Therapy?

What are Polyclonal Antibodies?

What are Polyclonal Antibodies?

The Future of Monoclonal Antibodies

The Future of Monoclonal Antibodies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.